Page last updated: 2024-11-02

piracetam and Leukemia

piracetam has been researched along with Leukemia in 1 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McKee, KE1
Etherton, MR1
Lovitch, SB1
Gupta, AS1
Micalizzi, DS1
Tierney, T1
Wadleigh, M1
Vaitkevicus, H1

Other Studies

1 other study available for piracetam and Leukemia

ArticleYear
A Man in His 40s With Headache, Lethargy, and Altered Mental Status.
    JAMA neurology, 2015, Volume: 72, Issue:9

    Topics: Adult; Antineoplastic Agents, Hormonal; Craniotomy; Dexamethasone; DNA Nucleotidylexotransferase; He

2015